Meet Our Team
Introducing the only non-invasive vagus nerve stimulation approved as a Class IIa medical device under the EU-MDR.
We, tVNS® Technologies GmbH, are pioneers in transcutaneous, non-invasive vagus nerve stimulation. Our product portfolio includes:
Currently the only transcutaneous, non-invasive vagus nerve stimulation device approved in Europe under the new Medical Device Regulation (MDR EU 2017/745).
A transcutaneous, non-invasive vagus nerve stimulation device developed specifically for the treatment of migraine (expected to be available from July 2026).
Our tVNS® R device offers full wireless programmability for comprehensive clinical studies. With the tVNS® Research and tVNS® Patient apps, adjustment of stimulation parameters, data capture, and patient feedback are seamlessly integrated.
Our tVNS® R device offers full wireless programmability for comprehensive clinical studies. With the tVNS® Research and tVNS® Patient apps, parameter adjustment, data capture, and patient feedback are seamlessly integrated. To support clinical studies, we also provide a comprehensive CB safety report for ethics approvals and access to a global network of experts.
With the tVNS® Research App you can wirelessly set many parameters such as frequency, pulse width, current strength, and stimulation intervals. In addition, we offer a separate PC-based tVNS® Manager software. This enables responses to external trigger signals (e.g., ECG R-wave triggers generated by an external ECG system and transmitted to a PC). This allows closed-loop or triggered tVNS® in a scientific setup.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
